GlassScriptPhysician profile
Guangzhi Qu
NPI 1790780716
$58,567.80
in general payments reported to CMS, 2019-2025
83 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $9,843 · 2021: $2,259 · 2022: $14K · 2023: $5,639 · 2024: $3,017 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,562 · Consulting Fee: $9,130 · Education: $282 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,561.58 |
| Consulting Fee | $9,130.00 |
| Education | $281.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $158.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $7,426.50 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $7,151.34 | 2020-2025 | Xpovio |
| Astrazeneca Pharmaceuticals LP | $6,315.49 | 2019-2025 | Tagrisso, Imfinzi, Enhertu |
| Catalyst Pharmaceuticals, INC. | $5,237.81 | 2020-2023 | Firdapse |
| Rigel Pharmaceuticals, INC. | $4,500.35 | 2019-2024 | Rezlidhia, Tavalisse |
| Pfizer INC. | $4,311.11 | 2019-2025 | |
| Janssen Biotech, INC. | $3,909.66 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Genzyme Corporation | $2,559.71 | 2019-2024 | |
| Beone Medicines USA, INC. | $2,011.13 | 2025 | Tevimbra, Brukinsa |
| Exelixis INC. | $1,829.05 | 2019-2025 | Cabometyx |
| Genentech USA, INC. | $1,759.34 | 2019-2025 | Polivy, Venclexta, Rituxan Hycela |
| Verastem, INC. | $1,320.00 | 2020 | |
| Merck Sharp & Dohme LLC | $1,043.64 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Celgene Corporation | $999.48 | 2019-2025 | Reblozyl, Opdualag, Breyanzi |
| E.R. Squibb & Sons, L.L.C. | $753.17 | 2019-2025 | Opdivo |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $620.45 | 2019-2025 | Imdelltra (Amg757) |
| Astellas Pharma US INC | $446.06 | 2019-2025 | Vyloy, Xtandi |
| Daiichi Sankyo INC. | $354.67 | 2019-2025 | Enhertu, Injectafer |
| Gilead Sciences, INC. | $341.15 | 2021-2025 | Trodelvy |
| Incyte Corporation | $333.48 | 2019-2025 | Jakafi, Monjuvi |
| Eisai INC. | $303.13 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $291.63 | 2019-2025 | Alunbrig, Ninlaro, Fruzaqla |
| Kite Pharma, INC. | $279.81 | 2021-2025 | Yescarta |
| Abbvie INC. | $247.94 | 2019-2025 | |
| Beigene USA, INC. | $243.84 | 2021-2025 | Brukinsa, Tevimbra |
| Lilly USA, LLC | $232.15 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Seagen INC. | $227.94 | 2021-2025 | Padcev, Tukysa, Adcetris |
| Tersera Therapeutics LLC | $203.91 | 2021-2025 | Zoladex |
| Sanofi-Aventis U.S. LLC | $196.78 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $193.24 | 2019-2025 | Onivyde, Somatuline Depot |
| Puma Biotechnology, INC. | $185.37 | 2019-2025 | |
| Glaxosmithkline, LLC. | $175.00 | 2022-2025 | Jemperli, Zejula, Ojjaara |
| Bayer Healthcare Pharmaceuticals INC. | $136.57 | 2020-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $115.91 | 2019-2023 | Imbruvica |
| Array Biopharma INC | $108.32 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Deciphera Pharmaceuticals INC. | $107.14 | 2021-2025 | Qinlock, Tgct, Romvimza |
| Spectrum Pharmaceuticals INC. | $106.09 | 2019-2025 | Rolvedon |
| Regeneron Healthcare Solutions, INC. | $105.16 | 2021-2025 | Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.55 | 2019-2024 | Gilotrif |
| Adc Therapeutics America, INC. | $94.94 | 2022-2025 | |
| Genentech, INC. | $90.06 | 2023 | Tecentriq |
| Stemline Therapeutics INC. | $86.45 | 2023-2025 | Orserdu |
| Amneal Pharmaceuticals LLC | $84.62 | 2024 | |
| Paratek Pharmaceuticals, INC. | $80.93 | 2023-2024 | Nuzyra |
| Emd Serono, INC. | $80.60 | 2021-2025 | |
| Acrotech Biopharma INC. | $79.91 | 2023-2025 | Beleodaq |
| G1 Therapeutics, INC. | $72.35 | 2022-2023 | Cosela |
| Pharmacosmos Therapeutics INC. | $72.18 | 2021-2024 | Cosela |
| Jazz Pharmaceuticals INC. | $64.39 | 2020-2022 | |
| Mirati Therapeutics, INC. | $63.90 | 2023-2024 | Krazati |
| Recordati_rare_diseases_inc. | $63.62 | 2024-2025 | Sylvant |
| Morphosys, US INC. | $59.15 | 2021-2023 | Monjuvi |
| Octapharma USA, INC. | $54.81 | 2024-2025 | Octagam Immune Globulin (Human) |
| Servier Pharmaceuticals LLC | $51.75 | 2022-2025 | |
| Genmab U.S., INC. | $50.60 | 2022-2025 | Epkinly |
| Sobi, INC | $47.39 | 2023-2025 | |
| Blueprint Medicines Corporation | $42.00 | 2022 | |
| Adaptive Biotechnologies Corporation | $38.44 | 2023-2024 | Clonoseq |
| Taiho Oncology, INC. | $38.23 | 2022-2025 | |
| Epizyme, INC. | $30.14 | 2021-2022 | |
| Heron Therapeutics, INC. | $28.83 | 2020 | |
| Cti Biopharma Corp. | $27.94 | 2022-2023 | Vonjo |
| Beckman Coulter, INC. | $27.19 | 2021 | |
| Alexion Pharmaceuticals, INC. | $27.16 | 2019 | |
| Secura Bio, INC. | $27.12 | 2022 | |
| Clovis Oncology, INC. | $26.42 | 2019-2021 | |
| Aveo Pharmaceuticals, INC. | $24.93 | 2024 | |
| Inari Medical, INC. | $21.35 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi US Services INC. | $21.08 | 2025 | |
| Legend Biotech USA INC. | $19.73 | 2024 | |
| Pharmaessentia USA Corporation | $19.32 | 2025 | Besremi |
| Springworks Therapeutics, INC. | $18.84 | 2024 | Ogsiveo |
| Janssen Pharmaceuticals, INC | $18.38 | 2019 | |
| Tempus Ai, INC | $17.80 | 2024 | |
| Apellis Pharmaceuticals, INC. | $15.17 | 2023 | Empaveli |
| Lexicon Pharmaceuticals, INC. | $14.46 | 2020 | |
| Alnylam Pharmaceuticals INC. | $14.31 | 2022 | |
| Novocure INC. | $13.86 | 2019 | |
| Kyowa Kirin, INC. | $13.35 | 2021 | |
| Tesaro, INC. | $12.70 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.43 | 2019 | |
| Agios Pharmaceuticals, INC. | $10.90 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guangzhi Qu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.